Neurocognitive effects of atypical antipsychotics in patients with first-episode schizophrenia.

Conclusion: All three atypical antipsychotics tested in the study can potentially improve cognitive performance in first-episode schizophrenia, but no significant difference in the degree of improvement was found between drugs.
PMID: 32496921 [PubMed - as supplied by publisher]

Source: Nordic Journal of Psychiatry - June 6, 2020 Category: Psychiatry Tags: Nord J Psychiatry Source Type: research